Explore
Trendline
Tonix Pharmaceuticals to Announce Q2 2026 Financial Results Amid Expanding Treatment Portfolio
Tonix Pharmaceuticals to Announce Q2 2026 Financial Results Amid Expanding Treatment Portfolio
Read More
Trendline
Rosen Law Firm Urges GRAIL, Inc. Investors to Act Before August 4 Deadline in Securities Class Action
Rosen Law Firm Urges GRAIL, Inc. Investors to Act Before August 4 Deadline in Securities Class Action
Read More
Trendline
Rosen Law Firm Urges GRAIL Investors to Act Before Class Action Deadline
Rosen Law Firm Urges GRAIL Investors to Act Before Class Action Deadline
Read More
Trendline
Kiniksa Pharmaceuticals' IL 1 Franchise Expansion Boosts Earnings Forecast
Kiniksa Pharmaceuticals' IL 1 Franchise Expansion Boosts Earnings Forecast
Read More
Trendline
Shiva Scientific Seeks Specialist to Advance Oncogenomics and Molecular Applications
Shiva Scientific Seeks Specialist to Advance Oncogenomics and Molecular Applications
Read More
Trendline
GeoVax Labs Reports Q2 Loss and Advances Vaccine Study
GeoVax Labs Reports Q2 Loss and Advances Vaccine Study
Read More
Trendline
Outlook Therapeutics Secures FDA Approval for AMD Drug Lytenava
Outlook Therapeutics Secures FDA Approval for AMD Drug Lytenava
Read More
Trendline
Legacy Health Works Appoints Kylar Denae Williams as CEO to Lead AI-Driven Healthcare Innovations
Legacy Health Works Appoints Kylar Denae Williams as CEO to Lead AI-Driven Healthcare Innovations
Read More
Trendline
Cracker Barrel CEO Julie Masino to Step Down Amid Leadership Transition
Cracker Barrel CEO Julie Masino to Step Down Amid Leadership Transition
Read More
Trendline
Cracker Barrel Announces Leadership Change with New CEO Appointment
Cracker Barrel Announces Leadership Change with New CEO Appointment
Read More
Trendline
AtriCure Announces Strong Second Quarter 2026 Financial Results with Increased Revenue and Profitability
AtriCure Announces Strong Second Quarter 2026 Financial Results with Increased Revenue and Profitability
Read More
Trendline
Sanofi Halts Atopic Dermatitis Trials Following Efficacy Concerns
Sanofi Halts Atopic Dermatitis Trials Following Efficacy Concerns
Read More